Grant: Discovery Launch Supplement
University of Alberta
$12,500.00
Spatiotemporal Pathways Regulating Insulin Secretion Research Program: Fundamental Insights into GPx4-Dependent Redox Regulation.
EF 2024-25
Résumé
The body has various mechanisms to maintain the correct blood sugar (glucose) levels. Multiple chemical messengers are used to increase blood glucose levels from the body's reserve stores when more glucose is required, like during physical activity. However, the insulin hormone produced by beta cells in the pancreas is the only chemical messenger that can lower blood glucose levels to their proper physiological levels after a meal, for instance. The disruption of insulin release is the major cause of diabetes which is one of the major health issues in Canada. Unfortunately, our understanding of the mechanisms that activate beta cells to control the release of the right amount of insulin the body needs in physiological conditions is insufficient. As I establish my new laboratory, I will develop a long-term research program to tackle this fundamental question. Particularly, in this research proposal, we aim to study the protein named glutathione peroxidase 4 (GPx4) and its role in regulating insulin release by beta cells. We propose that GPx4 acts as a dimmer switch to promote the release of insulin when the glucose concentration increases. By utilizing high-throughput experimental techniques, we will investigate the following specific aims:
- Aim 1: We will visualize the rapid and precise regulation of insulin secretion processes by GPx4 in real-time.
- Aim 2: We will identify other proteins interacting with GPx4 to coordinate the insulin release.
- Aim 3: We will determine the mechanisms of how glucose regulates GPx4 and its associated protein activities to control insulin release.
By delving into this vital process, my ultimate goal is to pave the way for scientific advancements in understanding the tightly regulated process of insulin release that maintains physiological blood sugar levels. Moreover, our research group is unequivocally committed to promoting equity, diversity, and inclusion while delivering unparalleled training and mentoring opportunities to highly qualified personnel who will make an impact in Canada and worldwide.
Programme
Discovery Launch Supplement
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
DGECR-2024-00335
Name nom
Ferdaoussi, Mourad
Department département
Faculty Saint-Jean
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
12500
Program id
DGECR
Program name en
Discovery Launch Supplement
Program name fr
Supplément Tremplin vers la découverte
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5503
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Endocrinology
Research subject fr
Endocrinologie
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Spatiotemporal Pathways Regulating Insulin Secretion Research Program: Fundamental Insights into GPx4-Dependent Redox Regulation.
Keywords
insulin secretion; redox; mitochondrial homeostasis; lipid peroxidation; 4-hne; post-translational modification; high resolution imaging; proteomics
Application summary
The body has various mechanisms to maintain the correct blood sugar (glucose) levels. Multiple chemical messengers are used to increase blood glucose levels from the body's reserve stores when more glucose is required, like during physical activity. However, the insulin hormone produced by beta cells in the pancreas is the only chemical messenger that can lower blood glucose levels to their proper physiological levels after a meal, for instance. The disruption of insulin release is the major cause of diabetes which is one of the major health issues in Canada. Unfortunately, our understanding of the mechanisms that activate beta cells to control the release of the right amount of insulin the body needs in physiological conditions is insufficient. As I establish my new laboratory, I will develop a long-term research program to tackle this fundamental question. Particularly, in this research proposal, we aim to study the protein named glutathione peroxidase 4 (GPx4) and its role in regulating insulin release by beta cells. We propose that GPx4 acts as a dimmer switch to promote the release of insulin when the glucose concentration increases. By utilizing high-throughput experimental techniques, we will investigate the following specific aims:
- Aim 1: We will visualize the rapid and precise regulation of insulin secretion processes by GPx4 in real-time.
- Aim 2: We will identify other proteins interacting with GPx4 to coordinate the insulin release.
- Aim 3: We will determine the mechanisms of how glucose regulates GPx4 and its associated protein activities to control insulin release.
By delving into this vital process, my ultimate goal is to pave the way for scientific advancements in understanding the tightly regulated process of insulin release that maintains physiological blood sugar levels. Moreover, our research group is unequivocally committed to promoting equity, diversity, and inclusion while delivering unparalleled training and mentoring opportunities to highly qualified personnel who will make an impact in Canada and worldwide.